Paul Naske Archives | Cannabiz

We’re on a journey, says Rua chair, as capital raise falls short

by Steve Jones December 7, 2024December 9, 2024

Rua Bioscience has raised approximately NZ$1.2 million (A$1.1m) from investors as the company continued what chairwoman […]

Formal mediation fails to resolve Cann Group and Rua legal dispute but talks continue

by Steve Jones October 30, 2024October 30, 2024

Financial results: Rua Bioscience; Elixinol Wellness; Argent Biopharma; Wellnex Life; InhaleRx; Bioxyne

by Martin Lane and Steve Jones September 2, 2024September 3, 2024

Company news: Rua Bioscience; Avecho; Bioxyne/BLS; iX Biopharma; Ecofibre; Zelira

by Steve Jones and Martin Lane August 28, 2024November 25, 2024

Company news: Bioxyne/BLS; Rua Bioscience; Botanix; Melodiol Global Health; Zelira; Argent BioPharma

by Martin Lane and Steve Jones April 16, 2024July 16, 2024

Cann Group vows to ‘vigorously’ defend Rua claims as contract dispute goes legal

by Steve Jones February 16, 2024November 25, 2024

Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience

by Steve Jones and Martin Lane February 7, 2024November 25, 2024

Company news: Rua Bioscience; IDT Australia; Emyria; Elixinol Wellness; Neurotech; Hygrovest; Releaf Group/ICCM; Botanix

by Martin Lane August 30, 2023April 30, 2024

Company news: MedReleaf; Vitura Health; MGC Pharma; Rua Bioscience

by Martin Lane April 13, 2023April 30, 2024

Rua Bioscience vows to continue product supply despite taking axe to local manufacturing

by Steve Jones March 27, 2023April 30, 2024